(Sharecast News) - Pre-clinical antibody discovery specialists Fusion Antibodies said on Wednesday that it has been selected for three follow-on projects to its existing stable Cell Line Development project.
Fusion Antibodies said the original contract and the follow-on contracts all operate under a collaborative research and development agreement with an unnamed,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE